Related Experiment Video
Updated: Jan 20, 2026

Microfluidic Device for the Separation of Non-Metastatic MCF-7 and Non-Tumor MCF-10A Breast Cancer Cells Using AC Dielectrophoresis
Published on: August 11, 2022
PTP1B phosphatase as a novel target of oleuropein activity in MCF-7 breast cancer model
Paulina Przychodzen1, Alicja Kuban-Jankowska1, Roksana Wyszkowska1
1Department of Medical Chemistry, Medical University of Gdansk, Gdansk, Poland.
Abstract:
Phosphatase PTP1B has become a therapeutic target for the treatment of type 2-diabetes, whereas recent studies have revealed that PTP1B plays a pivotal role in pathophysiology and development of breast cancer. Oleuropein is a natural, phenolic compound with anticancer activity. The aim of this study was to address the question whether PTP1B constitutes a target for oleuropein in breast cancer MCF-7 cells. The cellular MCF-7 breast cancer model was used in the study. The experiments were performed using cellular viability tests, Elisa assays, immunoprecipitation, flow cytometry analyses and computer modelling. Herein, we evidenced that the reduced activity of phosphatase PTP1B after treatment with oleuropein is strictly correlated with decreased MCF-7 cellular viability and cell cycle arrest. These results provide new insight into further research on oleuropein and possible role of the compound in adjuvant treatment of breast cancer.
Insights
Oleuropein, a natural compound, inhibits phosphatase PTP1B activity in breast cancer cells. This inhibition correlates with reduced cell viability and cell cycle arrest, suggesting oleuropein
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Protein tyrosine phosphatase 1B (PTP1B) is implicated in type 2 diabetes and breast cancer development.
- Oleuropein, a natural phenolic compound, exhibits anticancer properties.
Purpose of the Study:
- To investigate if PTP1B is a molecular target for oleuropein in MCF-7 breast cancer cells.
- To explore the effects of oleuropein on PTP1B activity and breast cancer cell behavior.
Main Methods:
- Utilized MCF-7 breast cancer cell models.
- Performed cellular viability assays, Elisa assays, immunoprecipitation, flow cytometry, and computer modeling.
Main Results:
- Oleuropein treatment led to reduced PTP1B activity in MCF-7 cells.
- Decreased PTP1B activity was correlated with reduced cellular viability and cell cycle arrest.
- Evidence suggests PTP1B is a target of oleuropein in this breast cancer model.
Conclusions:
- Oleuropein's inhibition of PTP1B activity impacts breast cancer cell viability and cell cycle progression.
- These findings highlight oleuropein's potential as an adjuvant therapy for breast cancer.
- Further research into oleuropein's mechanism and therapeutic applications is warranted.
More Related Videos
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer
Co-activators and Co-repressors